klacid la 500mg modified release tablets
mylan ire healthcare limited - clarithromycin - modified-release tablet - 500 milligram(s) - macrolides; clarithromycin - antibacterial for systemic use, macrolide - it is indicated for treatment of infections caused by susceptible organisms. indications include: lower respiratory tract infections for example bronchitis and pneumonia. upper respiratory tract infections for example sinusitis and pharyngitis. skin and soft tissue infections for example folliculitis, cellulitis and erysipelas.
klacid la 500mg modified release tablets
viatris healthcare limited - clarithromycin - modified-release tablet - macrolides; clarithromycin
klacid
abbott australasia pty ltd - clarithromycin -
klacid hp7
abbott australasia pty ltd - clarithromycin; omeprazole; amoxycillin -
klacid 500mg f.c.tab.
abbott laboratories usa - coated tablet - 500 mg
atripla 300 mg tenofovir disoproxil fumarate/200 mg emtricitabine/600 mg efavirenz tablets bottle
gilead sciences pty ltd - efavirenz,emtricitabine,tenofovir disoproxil fumarate -
clorom xl 500 mg prolonged-release tablets
morningside healthcare (malta) limited - clarithromycin - prolonged-release tablet - 500 milligram(s) - macrolides; clarithromycin
klacid tablet 500mg
abbott laboratories (m) sdn. bhd. - clarithromycin -
klacid susp.125 125 mg/5ml
مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 125 mg/5ml - 125 mg/5ml
klacid susp.125 125 mg/5ml
مستودع أدوية أبوشيخة - abu sheikha drug store - clarithromycin 125 mg/5ml - 125 mg/5ml